Skip to main content
TipRanks
Go Ultimate75% OFF

Aurora Cannabis (ACB) Stock Price & Analysis

1,482 Followers

ACB Stock Chart & Stats

CA$6.47-CA$0.13(-1.97%)
At close: 4:00 PM EST
C$5C$6C$7Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
CAD 6.43 - CAD 6.60
52-Week Range
CAD 3.59 - CAD 8.75
Previous Close
CAD 6.60
Volume
N/A
Average Volume (3M)
480.20K
Market Cap
CAD 425.37M
Enterprise Value
CAD 250.46M
Total Cash (Recent Filing)
CAD 83.62M
Total Debt (Recent Filing)
CAD 21.43M
Price to Earnings (P/E)
―
Beta
1.62
Next Earnings
Feb 10, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

International Medical Growth

International medical growth and the rising share of revenue generated outside Canada indicate expanding access to regulated markets beyond the domestic business. This geographic diversification can support more durable growth and reduce reliance on Canadian demand over the next several quarters.

Margin And Production Advantages

A 58% adjusted gross margin provides a strong foundation for earnings if revenue stabilizes, while genetics-driven yield improvement could lower unit costs without requiring a proportional increase in the cost base. Together, these factors support potentially sustainable operating leverage.

Low-Leverage Balance Sheet

Nearly $150 million of liquidity with no debt gives Aurora meaningful financial flexibility relative to a leveraged operating profile. This supports continued investment in international capacity and acquisitions while reducing near-term solvency and refinancing pressure during the turnaround.

Bears Say

Revenue Contraction And Losses

Sharp TTM revenue contraction combined with renewed net losses shows that the business has not yet established stable scale economics. Even with a healthier gross margin, weaker demand can dilute fixed-cost absorption and make a durable return to profitability more difficult.

Negative Cash Generation

Ongoing negative operating and free cash flow means Aurora is still consuming cash rather than funding its business internally. If this persists, liquidity could gradually come under pressure and management may have less flexibility to finance capacity expansion or strategic opportunities.

Canadian Reimbursement Headwind

A roughly 30% reduction in Canadian medical reimbursement rates directly pressures Canadian medical revenue and adjusted gross profit. This structural policy change can weigh on near-term earnings and may require product, market, or cost adjustments before domestic economics recover.

Aurora Cannabis News

ACB FAQ

What was Aurora Cannabis’s price range in the past 12 months?
Aurora Cannabis lowest stock price was C$3.59 and its highest was C$8.75 in the past 12 months.
What is Aurora Cannabis’s market cap?
Aurora Cannabis’s market cap is C$425.37M.
When is Aurora Cannabis’s upcoming earnings report date?
Aurora Cannabis’s next earnings report is estimated for Feb 10, 2027 (not yet confirmed), which is in 83 days.
How were Aurora Cannabis’s earnings last quarter?
Aurora Cannabis released its earnings results on Nov 05, 2026. The company reported -C$0.32 earnings per share for the quarter, missing the consensus estimate of -C$0.088 by -C$0.232.
Is Aurora Cannabis overvalued?
According to Wall Street analysts Aurora Cannabis’s price is currently Undervalued.
Does Aurora Cannabis pay dividends?
Aurora Cannabis does not currently pay dividends.
What is Aurora Cannabis’s EPS estimate?
Aurora Cannabis’s EPS estimate is -0.07.
How many shares outstanding does Aurora Cannabis have?
Aurora Cannabis has 65,745,100 shares outstanding.
What happened to Aurora Cannabis’s price movement after its last earnings report?
Aurora Cannabis reported an EPS of -C$0.32 in its last earnings report, missing expectations of -C$0.088. Following the earnings report the stock price went down -0.274%.
Which hedge fund is a major shareholder of Aurora Cannabis?
Currently, no hedge funds are holding shares in TSE:ACB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology